Beijing Tong Ren Tang Chinese Medicine Company Limited announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2016. For the quarter, the company reported revenue of HKD 276,628,000 compared to HKD 250,118,000 a year ago. Operating profit was HKD 148,682,000 compared to HKD 114,850,000 a year ago. Profit before income tax was HKD 149,968,000 compared to HKD 117,252,000 a year ago. Profit attributable to owners of the company was HKD 120,136,000 or HKD 0.14 per basic and diluted share compared to HKD 90,124,000 or HKD 0.11 per basic and diluted share a year ago. For the six months, the company reported revenue of HKD 541,950,000 compared to HKD 484,117,000 a year ago. Operating profit was HKD 286,155,000 compared to HKD 218,900,000 a year ago. Profit before income tax was HKD 288,696,000 compared to HKD 223,807,000 a year ago. Profit attributable to owners of the company was HKD 228,552,000 or HKD 0.27 per basic and diluted share compared to HKD 173,126,000 or HKD 0.21 per basic and diluted share a year ago. Net cash generated from operating activities was HKD 251,562,000 compared to HKD 190,560,000 a year ago. Purchase of property, plant and equipment was HKD 7,371,000 compared to HKD 14,690,000 a year ago. Deposit paid for purchase of property, plant and equipment was HKD 1,498,000 compared to HKD 785,000 a year ago. During the Period, the Group's capital expenditure was HKD 7.7 million (2015: HKD 16.6 million), which was mainly used in the establishment of new overseas retail outlets, purchase of property and production equipment.